As healthcare professionals, it is imperative to stay informed about diseases that significantly impact our patients' lives, such as Parkinson's Disease (PD). This neurodegenerative disorder affects millions globally and presents unique challenges due to its progressive nature and diverse symptomatology.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to an imbalance in dopamine and acetylcholine. This imbalance results in motor and non-motor symptoms. The presence of Lewy bodies, protein aggregates mainly composed of alpha-synuclein, is another hallmark of PD.
PD typically manifests with motor symptoms such as tremors, bradykinesia, rigidity, and postural instability. However, non-motor symptoms like autonomic dysfunction, cognitive impairment, and mood disorders often precede motor symptoms and impact the quality of life significantly.
Diagnosis of PD is primarily clinical, based on history and physical examination. There are no definitive diagnostic tests, but neuroimaging can aid in differential diagnosis. Management involves pharmacological treatment, primarily levodopa, and non-pharmacological interventions like physiotherapy and occupational therapy.
Research is ongoing to understand the genetic and environmental factors contributing to PD, and to develop disease-modifying therapies. Deep Brain Stimulation (DBS) and stem cell therapy are promising advancements in the field.
Understanding Parkinson's Disease is crucial for healthcare professionals to provide comprehensive care. Staying updated with the latest research and advancements can help improve the quality of life for our patients and pave the way for future breakthroughs in management strategies.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation